Evidera (PPD) Acquires Medimix International

United BioSource (UBC) Acquires Evidinno Outcomes Research

January 5, 2026

Healthcare Services

United BioSource LLC (UBC) acquired Evidinno Outcomes Research Inc., a Vancouver-based healthcare research consulting firm specializing in real-world evidence (RWE), epidemiology, evidence synthesis, and health economics/HEOR. The acquisition will expand UBC’s evidence generation and late-stage/post-approval capabilities, with Evidinno operating as a wholly owned subsidiary.

Evident Acquires Pramana, Inc.

November 7, 2025

Medical Devices

Evident has completed its acquisition of Pramana, Inc., a Cambridge-based developer of autonomous whole slide imaging systems for digital pathology. The deal brings Pramana's AI-powered imaging and workflow technology into Evident's microscopy and optical-imaging portfolio to accelerate digital pathology capabilities and broaden solutions for hospitals, research institutions, and laboratories.

Datavant to Acquire Aetion, Creating an End-to-End Real-World Evidence Platform

July 13, 2025

Healthcare Services

Datavant signed an agreement to acquire Aetion, a real-world evidence (RWE) platform used for healthcare and life sciences decision-making. The combined offering is intended to provide end-to-end RWE capabilities spanning data discovery, linkage, privacy, curation, and advanced analysis for regulators and industry stakeholders.

Veranex Acquires Medidee to Expand European MedTech Capabilities

September 20, 2022

Healthcare Services

Veranex has acquired Medidee, a Lausanne-based MedTech regulatory and clinical consultancy, expanding Veranex's footprint and capabilities across Europe, India and APAC. The deal strengthens Veranex’s regulatory affairs, clinical development, and quality assurance services for medical device and in vitro diagnostic clients; financial terms were not disclosed.

OptimizeRx Acquires EvinceMed Specialty Drug Market Access Platform

March 15, 2022

Healthcare Services

OptimizeRx Corporation acquired the EvinceMed platform and related assets to integrate end-to-end automation for specialty pharmaceutical transactions into its point-of-care network. The purchase expands OptimizeRx’s capabilities for specialty drug prescribing, patient enrollment into manufacturer support programs, and point-of-dispense connectivity to improve patient access and accelerate time-to-therapy.

TriNetX Acquires Advera Health Analytics

January 21, 2022

Data & Analytics

TriNetX has acquired Advera Health Analytics, the developer of the Evidex pharmacovigilance platform, to integrate Advera’s drug safety software and datasets into its real-world data network. The deal aims to give life sciences clients real-time safety signal detection, validation, and investigation capabilities by combining Evidex with TriNetX’s federated clinical datasets.